Antares Pharma Income Statement
View: Annual
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 5.7 | 7.9 | 4.3 |
| Cost of Goods Sold | 2.0 | 3.4 | 1.6 |
| Gross Profit | 3.6 | 4.4 | 2.7 |
| Gross Profit Margin | 64.3% | 56.2% | 63.5% |
| SG&A Expense | 8.0 | 7.7 | 7.2 |
| Depreciation & Amortization | 0.3 | 0.3 | 0.3 |
| Operating Income | -- | -- | -- |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | (0.0) | (0.0) | (0.2) |
| Nonoperating Expenses | (0.5) | -- | -- |
| Income Before Taxes | -- | -- | -- |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | 0.0 | 0.0 | 0.0 |
| Continuing Operations | (12.7) | (8.6) | (8.1) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (12.7) | (8.6) | (8.1) |
| Total Net Income | (12.7) | (8.6) | (8.1) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.19) | (0.14) | (0.16) |
| Dividends per Share | 0.00 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
